NEWS
Crown Aesthetics Introduces SkinPen® Premium Biocellulose Masque
Date: 02/06/2023
Crown Aesthetics, a division of Crown Laboratories, is excited to announce the launch of its new Premium Biocellulose Masque for post-treatment skin soothing. This new addition to the SkinPen® Precision Treatment Kits and MicroPen EVO™ Turbo Safety Kits marks the first premium upgrade to the Treatment Kit options from Crown Aesthetics.
Crown Aesthetics Introduces BIOJUVE™, a Revolutionary First of Its Kind, Living Skin Biome Care, Clinically Proven to Deliver Results, 24/7
Date: 01/23/2023
Crown Aesthetics, a Crown Laboratories, Inc. company, is excited to announce the launch of BIOJUVE™, a novel skin biome brand that uses a clinically-proven, living microbe technology to optimize the overall skin biome and lead to healthier, younger-looking skin.
Crown Aesthetics Announces Revolutionary Study Proving Efficacy of Patented Xycrobe® Technology
Date: 11/27/2022
Crown Aesthetics, a Crown Laboratories, Inc. company, maintains its position at the forefront of skincare innovation with the unveiling of a new study in the Journal of Cosmetic Dermatology showcasing the efficacy of its patented Xycrobe® technology, formulated to address the often overlooked skin biome. Xycrobe technology targets certain skin conditions and cosmetic treatments using an isolated, living strain of skin-relevant bacteria.
SkinPen® Precision Recognized as “Best in Industry” in the 2022 Aesthetic Guide Awards
Date: 10/13/2022
Crown Aesthetics, a division of Crown Laboratories and the global leader in microneedling technology, is proud to share that SkinPen Precision was named “Best in Industry – Nonsurgical Innovation” in the Aesthetic Awards.
Crown Laboratories Acquires Eclipse MedCorp, LLC Assets
Date: 05/24/2022
Crown Laboratories has finalized an agreement with Eclipse, a medical technology company, to acquire its global, aesthetics-focused assets. The acquisition expands Crown’s aesthetics’ product portfolio and enhances Crown’s overall value proposition as a global leader in science-based aesthetic skincare solutions.
Modern Aesthetics News: Take Five with Jeff Bedard
Date: 01/03/2022
Crown Laboratories President and CEO, Jeff Bedard, spoke with Modern Aesthetics magazine about the company’s diverse offerings and its future plans. As a fully integrated global skincare company, our goal is “Skin Science for Life” and Crown Aesthetics, a division of Crown Laboratories which includes SkinPen Precision and ProGen Advantage, is thrilled to be a part of the company’s growth.
Crown Aesthetics Announces SkinPen® Precision Ambassador Program in Celebration of National Microneedling Day
Date: 10/26/2021
Crown Aesthetics, a division of Crown Laboratories, Inc. and the global leader in microneedling technology, has formally announced the launch of their SkinPen® Ambassador Program in conjunction with National Microneedling Day.
SkinPen® Precision Wins the 2021 Aesthetic Award for Best Nonsurgical Technology in the Industry
Date: 10/12/2021
Crown Aesthetics, a division of Crown Laboratories and the global leader in microneedling technology, is proud to announce that SkinPen Precision has again been recognized as an industry best for its superior innovation and technology. Presented by The Aesthetic Guide, the Aesthetic Awards shine a spotlight on product manufacturers and practice management companies that are shaping the future of aesthetic medicine.
MATV News: Crown to Acquire StriVectin
Date: 09/20/2021
Crown Laboratories is excited to expand it’s offerings in the skincare space by acquiring StriVectin. StriVectin’s products will become part of Crown’s new Premium Skincare Division and will operate as a wholly owned subsidiary of Crown Laboratories. “Partnering with StriVectin is an exciting and significant next step in diversifying and scaling our organization,” said Jeff Bedard, Crown Laboratories CEO.
Crown Laboratories to Acquire StriVectin®, the #1 Independent Prestige Skincare Company in the U.S.
Date: 8/26/2021
Crown Aesthetics, a division of Crown Laboratories, today announced that they have entered into a definitive agreement under which Crown will acquire StriVectin. The transaction is expected to close by mid-September 2021 and is subject to regulatory approvals and other customary closing conditions.
Crown Aesthetics, proud provider of ProGen PRP™ Advantage and SkinPen® Precision, announces partnership with Cosmetic Skin & Surgery Center
Date: 6/29/2021
Crown Aesthetics, a division of Crown Laboratories, is thrilled to announce that Dr. Jeffrey Rapaport, Medical Director and Founder of Cosmetic Skin & Surgery Center, will be partnering with Crown Laboratories’ Medical Affairs team to help support our customers’ practices with medical education, clinical support and KOL development.
SkinPen® Precision Now Under Direct Management in the United Kingdom and Ireland
Date: 4/12/2021
Crown Aesthetics is delighted to announce that SkinPen Precision, the first microneedling device cleared by the FDA and the gold standard for skin remodeling technology, now has a direct presence in the UK and Ireland.
Crown Aesthetics Proudly Announces New Indication For Treatment Of Neck Wrinkles For FDA-Cleared Microneedling System, SkinPen® Precision
Date: 4/8/2021
Crown Aesthetics, a division of Crown Laboratories, Inc. and the US leader in Microneedling Technology, announced today that the U.S. Food and Drug Administration (FDA) has cleared SkinPen® Precision for the treatment of wrinkles on the neck.
SKINPEN® PRECISION RECOGNIZED AS FAVORITE MICRONEEDLING DEVICE IN 2021 AESTHETICIANS’ CHOICE AWARDS
Date: 2/23/2021
Crown Aesthetics, a division of Crown Laboratories, Inc. and the US leader in Microneedling Technology, is proud to share that SkinPen Precision was named “Favorite Microneedling Device” in the Seventh Annual Aestheticians’ Choice Awards. The Aestheticians’ Choice Awards honor the best brands, products, devices and people in the industry as chosen by experts in the aesthetics field.
Crown Aesthetics Proudly Announces Class IIa CE Certification For BSI Evaluated Microneedling System, SkinPen® Precision
Date: 11/18/2020
Crown Aesthetics, a division of Crown Laboratories, Inc. and the leader in minimally invasive aesthetic treatments, announced today that the British Standards Institution (BSI) has awarded a Class IIa CE Certification mark to SkinPen® Precision. The certification confirms SkinPen as a treatment to improve the appearance of facial acne scars in adults aged 22 years or older and to improve the appearance of fine lines and wrinkles on the face and neck. The SkinPen is also intended to treat pigmentation conditions (dyschromia) including Melasma, Vitiligo and Solar Lentigines.
Crown Aesthetics continues to lead by example, demonstrating “Safety First” with transfer of PRP manufacturing facility to the USA
Date: 10/20/2020
Crown Aesthetics, a division of Crown Laboratories, Inc. and pioneers in advanced aesthetics solutions, sheds light on their dedication to patients’ safety following the decision to move all production of ProGen PRPTM, their FDA 510k approved Platelet Rich Plasma system, to a manufacturing facility in the United States as of December 2019.
Crown Aesthetics Receives Medical Device Single Audit Program Certification
Date: 1/30/2020
We are proud to announce today that it has received Medical Device Single Audit Program (MDSAP) certification after a rigorous audit by BSI (British Standards Institute). This secures ongoing distribution in Canada, Australia, Brazil and Japan.
Crown Aesthetics Receives Medical Device Single Audit Program Certification
Date: 1/30/2020
We are proud to announce today that it has received Medical Device Single Audit Program (MDSAP) certification after a rigorous audit by BSI (British Standards Institute). This secures ongoing distribution in Canada, Australia, Brazil and Japan.
Crown Aesthetics Announces Addition of ProGen PRP™ Advantage to ProGen PRP Portfolio
Date: 1/24/2020
Leader in advanced aesthetic solutions, Crown Aesthetics, a division of Crown Laboratories, Inc., is proud to announce the launch of ProGen PRP™ Advantange, an easy to use, single spin system that features 15mL and 30mL tubes, yielding 7-15mL of 2x concentration PRP.
Crown Laboratories Completes Commercial Integration Plan, Strengthens its Position in the Global Marketplace
Date: 1/20/2020
For the past two years Crown has been dedicated to transforming its Northeast Tennessee operations into a leading global skincare company. We have now restructured the commercial operations business units as we continue to elevate our new “Skin Science for Life” commitment.
Crown Aesthetics Announces New Esteemed Executive Management Leadership Team
Date: 4/02/2019
Dedicated to the three essential pillars that founded the company, Education, Technology and Customer Service, Crown Aesthetics, a division of Crown Laboratories, has announced the appointment of their extraordinary executive management leadership team.
Crown Aesthetics Wins Barry Knapp Award for U.K. Product Innovation of the Year
Date: 12/05/18
Each year the Barry Knapp Award for Product Innovation of the Year is presented in London at the renowned Aesthetics Awards. This award is for products launched in the U.K. that represent genuine innovation or product advancement leading to treatment for new indications, quicker or easier treatments, better treatment outcomes, enhanced patient safety, backed up by sound evidence.
Crown Aesthetics Now Part of Crown Laboratories
Date: 09/28/18
Crown Laboratories, Inc. and Hildred Capital Partners, LLC have acquired Crown Aesthetics.
Crown’s non-invasive offerings include the SkinPen, a medical grade microneedling device used exclusively by healthcare professionals to improve the appearance of facial acne scars. It is the first microneedling device to be granted clearance and marketing authorization by the FDA or this indication.
Crown Wins Record Number of Aesthetic Everything® Awards
Date: 10/23/18
The eight accolades exceed the company’s total of seven last year. Crown also won the inaugural award in the category of Top New FDA-Cleared Innovation. These honors follow Crown Aesthetics’s U.S. Food and Drug Administration (FDA) clearance for SkinPen. After a rigorous three-year evaluation process to meet more than 90 validated requirements for the microneedling device, charger base, and proprietary cartridge, Crown set a new standard as the first FDA-cleared microneedling device.
Crown Laboratories Acquires Crown Aesthetics
Date: 09/28/18
Crown Laboratories, Inc. (“Crown Laboratories”), a leading, fully integrated, specialty pharmaceutical company and Hildred Capital Partners LLC (“Hildred”) portfolio company, today announced it has acquired Crown Aesthetics, a leader in medical aesthetics treatments dedicated to delivering innovative repair and restoration products to aesthetic practices around the world.
SkinPen® Precision Microneedling Device Receives FDA Clearance Making it the ONLY Class II Safe and Legally Marketed Microneedling System in the U.S.
Date: 03/06/18
Crown Aesthetics has been granted clearance and immediate marketing authorization by the U.S. Food and Drug Administration (FDA) for its medical grade microneedling device, SkinPen® Precision. This is the first and only microneedling device in the industry to receive this important designation from the FDA, and sets a new standard as the only recognized Class II microneedling device available.
SkinPen® Precision is the First and Only Medical Grade Microneedling Device Approved in Australia
Date: 12/21/17
Crown Aesthetics expands the skin-enhancing benefits of the industry-leading SkinPen® Precision in Australia! SkinPen® Precision is Crown Aesthetics’s flagship product, and now with approval from the Therapeutic Goods Administration (TGA), Crown will partner with Advanced Skin Technology to distribute SkinPen® Precision to practitioners in Australia. TGA, the agency that regulates medical devices and pharmaceuticals in Australia, has approved the SkinPen® Precision microneedling system as a Class II medical device utilizing Collagen Induction Therapy (CIT) to treat Melasma, acne scars, and surgical scars.
7 Reasons to Choose Crown Aesthetics
Date: 09/20/17
Crown Aesthetics is honored to receive recognition in the aesthetic industry, topping the charts in seven categories presented by the Aesthetic Everything® 2017 Diamond Crystal Awards. Crown is proud to be recognized for leading the charge in microneedling technology, commitment to excellences as a top aesthetic company and CEO leadership.
SkinPen® Precision Microneedling System Now Available in Canada
Date: 08/31/17
Crown Aesthetics is pleased to announce that SkinPen® Precision is now available to medical practitioners in Canada. With Health Canada’s Medical Device license Number 99476, Crown will offer the complete SkinPen® microneedling system, including the SkinPen® Precision microneedling device, Skinfuse™ post-microneedling protocol and the Skinfuse™ treatment kit, to treat Melasma, acne, and surgical scars in Canada. The SkinPen® microneedling system raises the standard in technology and is backed by the highest medical device standards available to practices and their patients.
Crown Aesthetics Earns CE Mark for SkinPen and Accessories
Date: 07/11/17
We are excited to announce that Crown Aesthetics has completed CE Mark registration for our SkinPen® Microneedling Cartridge, SkinPen® Precision Microneedling Pen and Skinfuse® Lift Hydrogel. Specifically, this means Crown can now sell our SkinPen® microneedling system commercially to physicians within the European Union. Providing practices in Europe with a safe, reliable and effective device is an accomplishment for which we are extremely proud.
Crown Aesthetics Earns ISO 13485:2016 Certification
Date: 06/27/17
Crown Aesthetics recently earned the ISO 13485:2016 certification and leads the industry with this important designation. It’s the best internationally-accepted model a medical device provider can implement to demonstrate compliance to laws and regulations of the medical device industry. Crown is the first microneedling company to earn this designation!
Crown Aesthetics Appoints New Vice President of Sales
Date: 06/20/17
Crown Aesthetics welcomes Michael McKenna as the Vice President of Sales. This is a valuable addition to the executive leadership team, responsible for spearheading business development, strategic sales plans and positioning the company for continued growth and increased customer satisfaction.
Crown Aesthetics to Provide Expertise at Key Events in 2017
Date: 04/17/17
Crown Aesthetics will have an increased presence at premier skin care and aesthetics tradeshow events across the U.S. this year. The company sets the standard for customer focus by providing blockbuster products like SkinPen®, Skinfuse®, Benzocaine Lidocaine Tetracaine (BLT) and ProGen™ PRP, all of which represent the highest quality, safety and efficacy in the industry. For this reason, Crown Aesthetics and its team of experts will take part in key events as it looks to increase in-person product education, expand customer reach and further position itself a leader in the medical aesthetics industry.
Crown Aesthetics Introduces Benzocaine, Lidocaine, and Tetracaine Product Line
Date: 04/05/17
Crown Aesthetics launched a line of non-invasive, over the counter numbing gels, Benzocaine, Lidocaine, and Tetracaine (B,L,T) packaged in convenient and easy-to-use individual packets. The single use, individual packets of B (Benzocaine, 20%), L (Lidocaine 4%) and T (Tetracaine 2%), are manufactured according to FDA OTC Drug monograph standards, eliminating the need for a prescription while still providing safe and effective levels of numbing ingredients.
Crown Aesthetics Launches New Product ProGen PRP
Date: 02/22/17
Crown Aesthetics introduced ProGen™ PRP, the latest innovation in the delivery of Platelet Rich Plasma (PRP). The scientifically-validated system is the most flexible kit in the marketplace that can deliver 2x and 5.1x PRP. The flexibility, combined with a reduction in procedure time and consistently repeatable results, offers the best value in the PRP market.
The Big Reveal: Crown Aesthetics Unveils New Look
Date: 02/15/17
Crown Aesthetics unveiled a new brand identity as it prepares for significant growth and elevates its position as a global brand. Since 2012, the company focused on building a solid foundation and since has experienced a steady, healthy growth. As the business needs evolve, the company continues to respond to consumer demand, and rebranding is part of that evolution.
Crown Aesthetics Adds Esteemed Doctor to Team
Date: 01/24/17
Crown Aesthetics welcomes Marek Dobke, M.D. to the company’s team of medical experts. In his new role Dr. Dobke will provide physician oversight for in-house clinical studies and hands-on device training, among other clinically-related duties.